BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21607687)

  • 1. CD4 + CD25high regulatory T cell numbers and FOXP3 mRNA expression in patients with advanced esophageal cancer before and after chemotherapy.
    Xu T; Duan Q; Wang G; Hu B
    Cell Biochem Biophys; 2011 Nov; 61(2):389-92. PubMed ID: 21607687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.
    Yan B; Ye S; Chen G; Kuang M; Shen N; Chen S
    Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXP3 expression in blood, synovial fluid and synovial tissue during inflammatory arthritis and intra-articular corticosteroid treatment.
    Raghavan S; Cao D; Widhe M; Roth K; Herrath J; Engström M; Roncador G; Banham AH; Trollmo C; Catrina AI; Malmström V
    Ann Rheum Dis; 2009 Dec; 68(12):1908-15. PubMed ID: 19066178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alterations of CD4+ CD25+ regulatory T cells in patients with idiopathic thrombocytopenic purpura].
    Ling Y; Cao XS; Yu ZQ; Luo GH; Bai X; Su J; Dai L; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2007 Mar; 28(3):184-8. PubMed ID: 17649712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone upregulates FOXP3 expression without increasing regulatory activity.
    Prado C; Gómez J; López P; de Paz B; Gutiérrez C; Suárez A
    Immunobiology; 2011 Mar; 216(3):386-92. PubMed ID: 20667622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of 89SrCl2 treatment on CD4+ CD25+ regulatory T cells and its Foxp3 mRNA expression in cancer patients with bone metastases].
    Duan Y; Xu RS; Wu HW; He WG; Shu B
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Sep; 42(5):649-52. PubMed ID: 22007491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between the CD4+CD25high regulatory T cells and the outcome of chemotherapy in advanced esophageal carcinoma.
    Wang G; Sun Y; Ji C; He Y; Hu C; Jiang F; Chen M; Duan Q; Fan P; Hu B
    Hepatogastroenterology; 2013 Jun; 60(124):704-8. PubMed ID: 23262265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of CD4+ CD25+ regulatory T cells and expression of Foxp3 mRNA in bronchiolitis and glucocorticoid regulation].
    Zhu YF; Cai XH; Zhu JY; Jiang WP; Lan JH; Liu S
    Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(22):1563-6. PubMed ID: 19953886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
    Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY
    Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+CD25+ regulatory T cells in irritable bowel syndrome patients.
    Holmén N; Isaksson S; Simrén M; Sjövall H; Ohman L
    Neurogastroenterol Motil; 2007 Feb; 19(2):119-25. PubMed ID: 17244166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. End-stage renal failure and regulatory activities of CD4+CD25bright+FoxP3+ T-cells.
    Hendrikx TK; van Gurp EA; Mol WM; Schoordijk W; Sewgobind VD; Ijzermans JN; Weimar W; Baan CC
    Nephrol Dial Transplant; 2009 Jun; 24(6):1969-78. PubMed ID: 19193737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysfunction of CD4+CD25high T regulatory cells in patients with recurrent aphthous stomatitis.
    Lewkowicz N; Lewkowicz P; Dzitko K; Kur B; Tarkowski M; Kurnatowska A; Tchórzewski H
    J Oral Pathol Med; 2008 Sep; 37(8):454-61. PubMed ID: 18318707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic characterization of ex vivo CD4+CD25highCD127low immune regulatory T cells in allergic asthma: pathogenesis relevance of their FoxP3, GITR, CTLA-4 and FAS expressions.
    Pietruczuk M; Eusebio M; Kraszula L; Kupczyk M; Kuna P
    J Biol Regul Homeost Agents; 2012; 26(4):627-39. PubMed ID: 23241113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered expression of CD4(+)CD25(+) regulatory T cells and its 5-HT(1a) receptor in patients with major depression disorder.
    Li Y; Xiao B; Qiu W; Yang L; Hu B; Tian X; Yang H
    J Affect Disord; 2010 Jul; 124(1-2):68-75. PubMed ID: 19900711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased frequencies of CD4+ CD25+ FOXP3+ regulatory T cells in human nasal inverted papilloma.
    Gu Y; Wang C; Han D; Zhang L
    Head Neck; 2011 Jul; 33(7):1005-12. PubMed ID: 21674673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Foxp3 expression on normal and leukemic CD4+CD25+ T cells implicated in human T-cell leukemia virus type-1 is inconsistent with Treg cells.
    Abe M; Uchihashi K; Kazuto T; Osaka A; Yanagihara K; Tsukasaki K; Hasegawa H; Yamada Y; Kamihira S
    Eur J Haematol; 2008 Sep; 81(3):209-17. PubMed ID: 18510697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term anti-CD25 monoclonal antibody treatment and neogenetic CD4(+)CD25(high) regulatory T cells in kidney transplantation.
    Wang Z; Xiao L; Shi BY; Qian YY; Bai HW; Chang JY; Cai M
    Transpl Immunol; 2008 Apr; 19(1):69-73. PubMed ID: 18346640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of CD4+CD25+Foxp3+ regulatory T cells in patients of haemorrhagic fever with renal syndrome].
    Nie ST; Li Q; Wang HY
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):817-9. PubMed ID: 19595120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice.
    Qu Y; Zhang B; Zhao L; Liu G; Ma H; Rao E; Zeng C; Zhao Y
    Transpl Immunol; 2007 Apr; 17(3):153-61. PubMed ID: 17331841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic modulation of CD4+CD25(high) regulatory T lymphocytes in multiple sclerosis patients during interferon-β therapy.
    Cosentino M; Zaffaroni M; Trojano M; Giorelli M; Pica C; Rasini E; Bombelli R; Ferrari M; Ghezzi A; Comi G; Livrea P; Lecchini S; Marino F
    Neuroimmunomodulation; 2012; 19(5):283-92. PubMed ID: 22472872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.